论文部分内容阅读
目的研究沙美特罗/氟替卡松吸入剂治疗稳定期慢性阻塞性肺疾病的临床效果。方法选择在津市市人民医院就诊的稳定期慢性阻塞性肺疾病患者88例,随机分为对照组和治疗组,每组44例。对照组采用氨溴索片联合氨茶碱片治疗,治疗组采用沙美特罗/氟替卡松吸入剂治疗。结果治疗组患者呼吸功能恢复正常时间、肺部功能检查指标水平恢复正常时间、临床用药治疗总时间明显短于对照组,慢性阻塞性肺疾病治疗效果明显优于对照组,呼吸功能在用药前后的改善幅度明显高于对照组,药物原因导致的不良反应例数明显少于对照组。结论应用沙美特罗/氟替卡松吸入剂治疗稳定期慢性阻塞性肺疾病临床效果非常明显。
Objective To study the clinical effect of salmeterol / fluticasone inhalation on stable chronic obstructive pulmonary disease. Methods Eighty-eight patients with chronic obstructive pulmonary disease (COPD) in Tianjin People’s Hospital were randomly divided into control group and treatment group, 44 cases in each group. The control group was treated with ambroxol and aminophylline tablets, and the treatment group was treated with salmeterol / fluticasone inhalation. Results In the treatment group, the resumption of respiratory function was normal, the indexes of pulmonary function test recovered to normal time, the total time of clinical medication was significantly shorter than that of the control group, and the treatment effect of chronic obstructive pulmonary disease was significantly better than that of the control group. The improvement rate was significantly higher than the control group, the number of adverse reactions caused by drug causes was significantly less than the control group. Conclusion The clinical effect of salmeterol / fluticasone inhalation in the treatment of stable chronic obstructive pulmonary disease is very obvious.